查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014953

男士理容市場：2026-2032年全球市場預測（依治療類型、技術、服務提供者類型、治療頻率和效果持續時間分類）

Male Aesthetics Market by Treatment Type, Technology, Provider Type, Treatment Frequency, Outcome Duration - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，男士護理市場價值將達到 66.1 億美元，到 2026 年將成長至 71 億美元，到 2032 年將達到 111.7 億美元，複合年成長率為 7.77%。

主要市場統計數據
基準年 2025 66.1億美元
預計年份：2026年 71億美元
預測年份 2032 111.7億美元
複合年成長率 (%) 7.77%

男士理容市場不斷發展，在標準化、技術進步和數位化病人歷程的推動下，服務提供和價值創造正在重塑。

男士美容市場已從最初以少數診所和療程為主的小眾市場，發展成為現代個人護理和醫療服務的主流組成部分。最初，男士美容主要集中於美容領域，專注於少數幾種療程；如今，它涵蓋了廣泛的選擇，包括微創、非侵入性、外科手術和居家護理，並與皮膚科、頭髮護理和健康管理等領域相互交融。這種轉變反映了人口結構的變化和文化接受度的提高，越來越多的男性開始尋求能夠解決老齡化、脫髮、體型和皮膚健康等問題的服務，並且不再帶有任何偏見。

微創治療、核心能量技術和新型治療模式的快速融合正在重塑患者的期望和競爭動態。

多重變革正在匯聚，重塑男士美容市場，對策略遠見和營運靈活性提出了更高的要求。首先，隨著消費者尋求更溫和的替代方案，治療類別正在加速細分。如今，治療範圍已擴展至“微創手術”、“非侵入性手術”、“外科手術”以及“外用治療和居家護理”，其中脂肪移植、雷射輔助抽脂、抽脂和埋線拉提等特定技術與非手術毛髮再生、皮膚修復和塑形方法並存。其次，雷射、射頻和超音波等核心技術的普及，使醫療服務提供者能夠提供個人化、實證的治療方案，從而減少恢復時間並擴大應用範圍。

貿易政策的轉變正在重塑醫療設備、耗材和診所營運基礎的整個價值鏈的採購、定價和業務永續營運。

預計在2025年前後公佈的貿易政策趨勢，將為依賴跨國供應鏈的製造商、經銷商和診所帶來更複雜的商業環境。關稅調整加劇了醫療設備和居家醫療技術中使用的資本設備、耗材和專用組件的成本壓力。因此，採購團隊正在重新審視籌資策略和庫存政策，以減輕前置作業時間波動和利潤率下降的影響。同時，一些製造商正在加快區域性生產和組裝，以降低進口關稅的影響，並更快地應對當地法規和報銷機制的變化。

將治療方法、底層技術、交付模式和治療效果持續時間連結起來的多維細分框架揭示了策略性成長槓桿。

細分市場分析揭示了獨特的市場需求促進因素和營運重點，這些因素因治療類型、技術、交付模式、治療頻率和療效持續時間而異。依治療類型分類，競爭格局包括微創手術以及非侵入性、外科手術和局部/居家照護等形式。微創手術類別包括脂肪移植、雷射輔助抽脂、抽脂和埋線拉提。非侵入性手術則涵蓋塑形、肉毒桿菌注射、除毛、非手術生髮、色素沉澱/疤痕修復、皮膚修復和皮膚緊緻。外科手術包括身體整形、臉部整形和植髮，而局部/居家護理則包括居家護理設備和護膚。從技術角度來看，市場活動主要圍繞著雷射技術、射頻技術和超音波展開，每種技術都有不同的研發週期和臨床證據需求。從服務提供者類型來看，該生態系統涵蓋了理髮店旁的美容診所、皮膚科診所、連鎖加盟店和醫療美容中心，每個機構都會影響轉診流量、定價權和品牌建立。根據治療頻率，患者的治療路徑從維護/加強護理和單次治療到療程方案不等，從而形成終身價值模型。根據效果持續時間，治療結果​​分為“持久（24個月或以上）”、“永久性”、“半永久性（6-24個月）”或“暫時性（6個月或以下）”，這會影響預期管理和治療後溝通。

這些細分維度之間存在可預測的交互作用。療效持久的技術更傾向於應用於外科手術和微創領域，而非侵入性療法和家用設備則更適合常規維護。注重便利性和治療次數的醫療機構傾向於選擇短期治療方案和套餐計劃，而專科皮膚科診所則更注重循證的個人化治療方案，並收取更高的費用。了解這些交集有助於精準制定產品藍圖和市場進入策略，從而更好地契合臨床工作流程和病患偏好。

部署模式的區域差異和細微的監管差別，正在為美洲、歐洲、中東和非洲以及亞太市場創造獨特的機會。

區域趨勢造就了獨特的競爭格局和需求模式，直接影響商業化策略。在美洲，男性美容醫學的高消費者接受度以及醫療機構的高密度分佈，為差異化的診所模式和基於會員制的維護計劃創造了機會。該地區部分地區的法規環境和支付方互動促使診所採用靈活的定價結構和資金籌措方案，以擴大服務可近性，同時優先考慮臨床療效和病人安全。

將醫療設備創新與臨床醫生培訓、數位化和服務型收入模式結合的公司，在客戶採納和留存方面都優於競爭對手。

目前，主要企業之間的競爭呈現出整合打入市場策略的特點，這些策略融合了產品創新、培訓生態系統和服務交付能力。投資臨床醫生教育和認證計畫的公司能夠加速醫療設備的普及應用，降低治療結果的差異性，並最終提升產品高階定位和客戶復購率。同樣，建立可支援多種技術和治療適應症的模組化平台的公司能夠提高客戶終身價值，並降低合作診所的客戶流失率。

採取切實可行的策略措施，穩定價值鏈，實現治療結果貨幣化，並擴大對醫療保健提供者的覆蓋範圍，同時保持臨床可靠性和患者終身價值。

領導者應優先考慮一系列切實可行的措施，以兼顧短期韌性和中期成長。首先，透過供應商多元化、二級製造商認證以及評估區域組裝方案來降低供應鏈風險，從而減輕關稅造成的成本波動和交貨延遲。其次，透過投資高品質的臨床證據、真實世界結果追蹤以及支持高階定位和訂閱式服務的患者報告指標，將交易重點從價格轉向可驗證的結果。

嚴謹的混合方法，結合與關鍵相關人員的對話、整合二手證據和反覆檢驗，可確保獲得穩健的決策見解。

本調查方法結合了與領域專家的質性與量化訪談、權威的二級資訊來源、系統的資料檢驗流程。主要研究包括對臨床實踐、醫療設備製造、分銷和零售供應商等各領域代表性相關人員進行結構化訪談，以收集關於技術採納、報銷流程、患者偏好和營運挑戰的第一手觀點。此外，還透過對臨床醫生和診所營運人員的補充問卷調查，量化了治療頻率模式、典型病人歷程以及常見的採納障礙。

為了取得永續的成功，必須將臨床證據、具有韌性的營運結構和以消費者為中心的商業化相結合，同時也要應對政策和區域方面的複雜性。

男性美容醫學領域正日趨成熟，成為一個融合了臨床創新、消費行為和商業性智慧的多元化市場。能夠成功整合產品功能、顯著療效和可擴展的醫療服務支援系統的醫療機構和製造商將獲得顯著優勢。治療方法、底層技術和醫療服務提供者類型之間的相互作用，自然地創造了市場細分的機會，而這些機會可以透過個人化定價、資金籌措和病人參與策略來實現盈利。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按護理類型分類的男士美容市場

  • 微創治療
    • 脂肪移植
    • 雷射輔助脂肪分解
    • 抽脂手術
    • 埋線拉提
  • 非侵入性治療
    • 塑形
    • 肉毒桿菌注射
    • 除毛
    • （非手術）生髮
    • 改善色素沉澱和疤痕
    • 皮膚再生
    • 皮膚緊緻
  • 外科手術
    • 身體手術
    • 臉部手術
    • 植髮
  • 外用製劑和家庭護理
    • 家用護理設備
    • 護膚

第9章：男士美容市場：依技術分類

  • 雷射技術
  • 高頻
  • 超音波

第10章：以供應商類型分類的男性美容市場

  • 美容診所，附理髮店
  • 皮膚科診所
  • 特許經營連鎖店
  • 醫療水療中心

第11章：以護理頻率分類的男士美容市場

  • 維護/增壓
  • 單次會話
  • 系列

第12章：依效果持續時間分類的男士美容市場

  • 持久有效（24個月或更長）
  • 永遠
  • 半永久性（6-24個月）
  • 暫時（少於6個月）

第13章：男士美容市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：男士美容市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：男士美容市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國男士美容市場

第17章：中國男士美容市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbvie Inc.
  • Acumed, LLC by Colson Medical, LLC
  • Alma Lasers, Ltd.
  • Anthony Skin LLC
  • Candela Corporation
  • Cartessa Aesthetics
  • Cutera, Inc.
  • Cynosure, LLC
  • Galderma SA
  • Hanson Medical, Inc.
  • Implantech Associates Inc.
  • Inmode Ltd
  • Institut Straumann AG
  • Integra LifeSciences Corporation
  • Ipsen Pharma
  • Jeisys Medical Inc.
  • Johnson & Johnson Services Inc.
  • KLS Martin Group
  • Lattice Medical SAS
  • Medytox, Inc.
  • Merz Aesthetics, Inc.
  • Nobel Biocare Services AG
  • Quanta System SpA
  • Solta Medical by Bausch Health Companies Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43286DA08070

The Male Aesthetics Market was valued at USD 6.61 billion in 2025 and is projected to grow to USD 7.10 billion in 2026, with a CAGR of 7.77%, reaching USD 11.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.61 billion
Estimated Year [2026] USD 7.10 billion
Forecast Year [2032] USD 11.17 billion
CAGR (%) 7.77%

An evolving male aesthetics landscape driven by normalization, technological advances, and digital-first patient journeys reshaping service delivery and value creation

The male aesthetics sector has evolved from niche clinics and elective procedures into a mainstream component of contemporary personal care and medical services. What began as a primarily cosmetic conversation focused on a narrow set of interventions now includes a broad spectrum of minimally invasive, non-invasive, surgical, and at-home options that intersect with dermatology, hair care, and wellness. This shift reflects both demographic changes and cultural acceptance, where men increasingly seek services that address aging, hair loss, body composition, and skin health without stigma.

Advancements in device technologies, expanded provider footprints beyond traditional surgical settings, and growing consumer comfort with maintenance-driven regimens have collectively redefined patient journeys. In parallel, digital channels have compressed education cycles and normalized treatments through social proof and targeted content. These dynamics are reshaping clinical practice, capital allocation, training priorities, and retail positioning across the value chain. As a result, stakeholders from equipment manufacturers to clinic operators must reconcile clinical efficacy, operational scalability, and consumer convenience to remain competitive.

Looking forward, strategic differentiation will require combining clinical excellence with frictionless patient experiences, integrated digital touchpoints, and outcome-focused value propositions. Organizations that align clinical protocols with measurable aesthetic outcomes and pragmatic business models are best positioned to capture sustained demand as care pathways continue to diversify and mature.

Rapid convergence of less invasive modalities, core energy-based technologies, and new provider models rewriting patient expectations and competitive dynamics

Multiple transformative shifts are converging to reconfigure the male aesthetics market, and these changes demand both strategic foresight and operational agility. First, the fragmentation of treatment categories is accelerating as consumers seek less invasive alternatives; the treatment spectrum now spans Minimally Invasive Procedures, Non-Invasive Procedures, Surgical Procedures, and Topicals & At-Home options, while specific techniques such as Fat Transfer, Laser-Assisted Lipolysis, Liposuction, and Thread Lifts coexist alongside non-surgical Hair Restoration, Skin Resurfacing, and Body Contouring modalities. Second, the spread of core technologies including Laser Technology, Radiofrequency, and Ultrasound is enabling providers to deliver tailored, evidence-based protocols that shorten downtime and broaden candidacy.

Provider models are also shifting: traditional dermatology clinics now operate alongside franchised chains, medical spas, and hybrid barbershop-adjacent grooming clinics, creating new access points and competitive dynamics. Treatment frequency and outcome duration are increasingly central to consumer decision-making, with maintenance/booster models and series-based regimens becoming commonplace, and outcome expectations ranging from temporary to semi-permanent, long-lasting, or permanent results. Collectively, these shifts compel manufacturers and providers to prioritize device versatility, training ecosystems, and patient retention strategies.

As market players navigate these transitions, success will depend on integrating multidisciplinary clinical expertise, investing in evidence generation, and redesigning commercial models to serve both episodic and ongoing care needs effectively.

Trade policy shifts are reshaping sourcing, pricing, and operational resilience for devices, consumables, and clinic economics across the value chain

The cumulative impact of trade policy developments announced in and around 2025 is creating a more complex operating environment for manufacturers, distributors, and clinics reliant on cross-border supply chains. Tariff adjustments have increased the cost pressure on capital equipment, consumables, and specialized components used in devices and at-home technologies. As a result, procurement teams are reevaluating sourcing strategies and inventory policies to mitigate lead-time variability and margin erosion. In tandem, some manufacturers are accelerating regional manufacturing or assembly to reduce exposure to import duties and to respond more quickly to local regulatory or reimbursement changes.

On the demand side, higher landed costs are prompting selective price adjustments and a sharper emphasis on value communication to patients. Clinics are responding by refining service bundles, emphasizing outcome duration, and promoting treatment packages with maintenance or series-based architectures to preserve revenue predictability. Meanwhile, manufacturers are negotiating revised distribution agreements and exploring creative financing models, including equipment-as-a-service, to lower adoption barriers for providers.

Regulatory and customs compliance has also become more salient, with firms investing in enhanced documentation, classification accuracy, and trade counsel to avoid disruption. Ultimately, the cumulative effect of tariff shifts is to accelerate localization, deepen partnerships across the value chain, and intensify the focus on cost-to-serve optimization while maintaining clinical standards.

A multi-dimensional segmentation framework linking treatment modality, enabling technology, provider models, and outcome duration to reveal strategic growth levers

Segmentation analysis reveals differentiated demand drivers and operational priorities that vary by treatment type, technology, provider model, treatment frequency, and outcome horizon. Based on Treatment Type the competitive landscape includes Minimally Invasive Procedures alongside Non-Invasive Procedures, Surgical Procedures, and Topicals & At-Home formats; the Minimally Invasive Procedures category further encompasses Fat Transfer, Laser-Assisted Lipolysis, Liposuction, and Thread Lifts, while Non-Invasive Procedures extend through Body Contouring, Botox Injectables, Hair Removal, Hair Restoration (Non-Surgical), Pigment/Scar Correction, Skin Resurfacing, and Skin Tightening, and Surgical Procedures cover Body Surgery, Facial Surgery, and Hair Transplant, with Topicals & At-Home comprising At-Home Devices and Skincare. Based on Technology market activity centers around Laser Technology, Radiofrequency, and Ultrasound, each with distinct development cycles and clinical evidence requirements. Based on Provider Type the ecosystem spans Barbershop-Adjacent Grooming Clinics, Dermatology Clinics, Franchised Chains, and Medical Spas, which influence referral flows, pricing power, and brand building. Based on Treatment Frequency patient pathways range from Maintenance/Booster and One-Time interventions to Series-Based protocols, shaping lifetime value models. Based on Outcome Duration outcomes are framed as Long-Lasting (>24 Months), Permanent, Semi-Permanent (6-24 Months), or Temporary (<=6 Months), driving expectation management and post-procedure communication.

These segmentation axes interact in predictable ways: technologies that deliver longer outcome duration are more likely to be adopted in surgical and minimally invasive settings, while non-invasive approaches and at-home devices align with serial maintenance strategies. Provider types that emphasize convenience and volume favor quick-turn modalities and packaged plans, whereas specialty dermatology clinics prioritize evidence and bespoke protocols for premium pricing. Understanding these intersections enables product roadmaps and go-to-market approaches to be precisely targeted to clinical workflows and patient preferences.

Divergent regional adoption patterns and regulatory nuances creating tailored opportunities across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics are shaping distinct competitive and demand landscapes that have direct implications for commercialization strategies. In the Americas, consumer acceptance of male aesthetics is high and provider density is strong, which creates opportunities for differentiated clinic formats and subscription-oriented maintenance models. The regulatory environment and payer interplay in parts of the region encourage clinics to emphasize clinical validation and patient safety while adopting flexible pricing constructs and financing options to broaden accessibility.

Europe, Middle East & Africa present a heterogeneous mix of markets where cultural attitudes toward aesthetics, reimbursement frameworks, and provider credentialing vary significantly. Western European markets often prioritize clinical evidence and specialist-led care, while several markets in the Middle East show strong demand for surgical and premium aesthetic services driven by discretionary spending. Africa's markets are nascent but increasingly receptive to non-invasive and at-home offerings where access to specialist clinics is limited.

Asia-Pacific remains highly dynamic, with rapid uptake of minimally invasive and non-invasive technologies driven by urbanization, mobile-first consumer engagement, and strong demand for hair restoration and skin rejuvenation services. Regional manufacturing hubs and an active device ecosystem also make Asia-Pacific a focal point for innovation and cost-competitive production. These regional contrasts necessitate tailored channel strategies, regulatory navigation, and culturally informed marketing to achieve sustained adoption.

Companies that integrate device innovation with clinician training, digital enablement, and services-based revenue models outpace competitors in adoption and retention

Competitive behavior among leading players is now defined by integrated go-to-market strategies that combine product innovation, training ecosystems, and service enablement. Companies that invest in clinician education and certification programs strengthen device adoption and reduce variability in outcomes, which in turn supports premium positioning and repeat business. Similarly, firms that build modular platforms capable of supporting multiple technologies and treatment indications enhance customer lifetime value and reduce churn among clinic partners.

Strategic partnerships and ecosystem plays are increasingly common; manufacturers are collaborating with software vendors, financing partners, and clinical networks to deliver a full-stack solution that addresses procurement, training, patient acquisition, and outcome tracking. Mergers and acquisitions remain a lever for scale, enabling firms to secure distribution reach, complementary technologies, or in-clinic brands that accelerate market penetration. At the same time, nimble challengers that focus on specific subsegments-such as at-home devices or niche surgical tools-are pushing incumbents to prioritize speed-to-clinic and targeted evidence generation.

Ultimately, winning companies balance clinical rigor, commercial flexibility, and a services-oriented mindset, while deploying data to demonstrate outcomes, justify pricing, and refine segmentation strategies across provider types and regional markets.

Practical strategic moves to stabilize supply chains, monetize outcomes, and expand provider reach while preserving clinical integrity and patient lifetime value

Leaders should prioritize a set of actionable moves that address both near-term resilience and medium-term growth. First, de-risk supply chains by diversifying suppliers, qualifying secondary manufacturers, and evaluating regional assembly options to mitigate tariff-driven cost volatility and delivery delays. Second, shift commercial conversations from price to demonstrable outcomes by investing in high-quality clinical evidence, real-world outcome tracking, and patient-reported metrics that support premium positioning and subscription offerings.

Third, create differentiated provider value propositions through training academies, standardized protocols, and flexible financing models such as equipment-as-a-service that lower adoption barriers for smaller clinics. Fourth, expand access through hybrid distribution strategies that combine specialist partnerships with non-traditional channels such as grooming clinics and franchised chains, while ensuring appropriate credentialing and quality controls. Fifth, design consumer engagement strategies that reflect the treatment frequency and outcome duration most relevant to target segments-one-time procedural buyers will require different messaging than maintenance/booster audiences who value predictable, recurring care.

Finally, embed regulatory and trade scenario planning into strategic decision-making to prepare for policy shifts, and invest in digital patient journeys that streamline education, booking, and post-procedure follow-up to lock in lifetime value. Executing these priorities will enhance resilience and create the foundation for scalable, sustainable growth.

A rigorous mixed-methods approach combining primary stakeholder engagement, secondary evidence synthesis, and iterative validation to ensure robust, decision-ready insights

The research methodology combines primary qualitative and quantitative engagement with domain experts, triangulated with authoritative secondary sources and systematic data validation processes. Primary research included structured interviews with a representative cross-section of stakeholders across clinical practice, device manufacturing, distribution, and retail-facing providers to capture first-hand perspectives on technology adoption, reimbursement interplay, patient preferences, and operational challenges. Supplementary surveys with clinicians and clinic operators quantified treatment frequency patterns, typical patient journeys, and common barriers to adoption.

Secondary research entailed a methodical review of peer-reviewed clinical publications, regulatory guidance, patent filings, company disclosures, and conference proceedings to verify technological claims and evidence bases. Data triangulation ensured that trends observed in primary research aligned with documented clinical outcomes and public disclosures. The analysis also employed scenario modeling to stress-test supply chain and policy impacts, and internal validation workshops were conducted with external clinical advisors to ensure interpretive accuracy and practical relevance.

Throughout the process, quality controls included source attribution, conflict-of-interest assessments, and iterative refinement of assumptions based on emergent primary insights. This layered approach ensures that conclusions are robust, actionable, and relevant to decision-makers operating in a rapidly evolving male aesthetics environment.

Sustained success depends on aligning clinical evidence, resilient operations, and consumer-centric commercialization to navigate policy and regional complexity

The male aesthetics landscape is maturing into a multi-faceted market where clinical innovation, consumer behavior, and commercial ingenuity intersect. Providers and manufacturers that successfully align product capabilities with demonstrable outcomes and scalable provider enablement will capture disproportionate value. The interplay of treatment modality, enabling technology, and provider type creates natural segmentation opportunities that can be monetized through tailored pricing, financing, and patient engagement strategies.

Trade policy developments and regional differences add layers of complexity, but they also create incentives for localization, strategic partnerships, and new service models that reduce cost-to-serve and accelerate time-to-market. Companies that emphasize clinician education, invest in longitudinal outcome tracking, and incorporate flexible commercial structures will be best positioned to manage near-term headwinds while unlocking long-term growth. In sum, thoughtful alignment of clinical evidence, operational resilience, and customer-centric commercialization will determine which organizations lead the next phase of market expansion.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Male Aesthetics Market, by Treatment Type

  • 8.1. Minimally Invasive Procedures
    • 8.1.1. Fat Transfer
    • 8.1.2. Laser-Assisted Lipolysis
    • 8.1.3. Liposuction
    • 8.1.4. Thread Lifts
  • 8.2. Non-Invasive Procedures
    • 8.2.1. Body Contouring
    • 8.2.2. Botox Injectables
    • 8.2.3. Hair Removal
    • 8.2.4. Hair Restoration (Non-Surgical)
    • 8.2.5. Pigment/Scar Correction
    • 8.2.6. Skin Resurfacing
    • 8.2.7. Skin Tightening
  • 8.3. Surgical Procedures
    • 8.3.1. Body Surgery
    • 8.3.2. Facial Surgery
    • 8.3.3. Hair Transplant
  • 8.4. Topicals & At-Home
    • 8.4.1. At-Home Devices
    • 8.4.2. Skincare

9. Male Aesthetics Market, by Technology

  • 9.1. Laser Technology
  • 9.2. Radiofrequency
  • 9.3. Ultrasound

10. Male Aesthetics Market, by Provider Type

  • 10.1. Barbershop-Adjacent Grooming Clinics
  • 10.2. Dermatology Clinics
  • 10.3. Franchised Chains
  • 10.4. Medical Spas

11. Male Aesthetics Market, by Treatment Frequency

  • 11.1. Maintenance/Booster
  • 11.2. One-Time
  • 11.3. Series-Based

12. Male Aesthetics Market, by Outcome Duration

  • 12.1. Long-Lasting (>24 Months)
  • 12.2. Permanent
  • 12.3. Semi-Permanent (6-24 Months)
  • 12.4. Temporary (<=6 Months)

13. Male Aesthetics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Male Aesthetics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Male Aesthetics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Male Aesthetics Market

17. China Male Aesthetics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbvie Inc.
  • 18.6. Acumed, LLC by Colson Medical, LLC
  • 18.7. Alma Lasers, Ltd.
  • 18.8. Anthony Skin LLC
  • 18.9. Candela Corporation
  • 18.10. Cartessa Aesthetics
  • 18.11. Cutera, Inc.
  • 18.12. Cynosure, LLC
  • 18.13. Galderma SA
  • 18.14. Hanson Medical, Inc.
  • 18.15. Implantech Associates Inc.
  • 18.16. Inmode Ltd
  • 18.17. Institut Straumann AG
  • 18.18. Integra LifeSciences Corporation
  • 18.19. Ipsen Pharma
  • 18.20. Jeisys Medical Inc.
  • 18.21. Johnson & Johnson Services Inc.
  • 18.22. KLS Martin Group
  • 18.23. Lattice Medical SAS
  • 18.24. Medytox, Inc.
  • 18.25. Merz Aesthetics, Inc.
  • 18.26. Nobel Biocare Services AG
  • 18.27. Quanta System S.p.A.
  • 18.28. Solta Medical by Bausch Health Companies Inc.
  • 18.29. Stryker Corporation
  • 18.30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MALE AESTHETICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MALE AESTHETICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MALE AESTHETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MALE AESTHETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MALE AESTHETICS MARKET SIZE, BY FAT TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MALE AESTHETICS MARKET SIZE, BY FAT TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MALE AESTHETICS MARKET SIZE, BY FAT TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER-ASSISTED LIPOLYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER-ASSISTED LIPOLYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER-ASSISTED LIPOLYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MALE AESTHETICS MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MALE AESTHETICS MARKET SIZE, BY LIPOSUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MALE AESTHETICS MARKET SIZE, BY LIPOSUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MALE AESTHETICS MARKET SIZE, BY THREAD LIFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MALE AESTHETICS MARKET SIZE, BY THREAD LIFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MALE AESTHETICS MARKET SIZE, BY THREAD LIFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY CONTOURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY CONTOURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY CONTOURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MALE AESTHETICS MARKET SIZE, BY BOTOX INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MALE AESTHETICS MARKET SIZE, BY BOTOX INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MALE AESTHETICS MARKET SIZE, BY BOTOX INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR RESTORATION (NON-SURGICAL), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR RESTORATION (NON-SURGICAL), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR RESTORATION (NON-SURGICAL), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MALE AESTHETICS MARKET SIZE, BY PIGMENT/SCAR CORRECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MALE AESTHETICS MARKET SIZE, BY PIGMENT/SCAR CORRECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MALE AESTHETICS MARKET SIZE, BY PIGMENT/SCAR CORRECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN TIGHTENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN TIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN TIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MALE AESTHETICS MARKET SIZE, BY FACIAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MALE AESTHETICS MARKET SIZE, BY FACIAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MALE AESTHETICS MARKET SIZE, BY FACIAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MALE AESTHETICS MARKET SIZE, BY AT-HOME DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MALE AESTHETICS MARKET SIZE, BY AT-HOME DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MALE AESTHETICS MARKET SIZE, BY AT-HOME DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKINCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKINCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKINCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MALE AESTHETICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MALE AESTHETICS MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MALE AESTHETICS MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MALE AESTHETICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MALE AESTHETICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MALE AESTHETICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MALE AESTHETICS MARKET SIZE, BY BARBERSHOP-ADJACENT GROOMING CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MALE AESTHETICS MARKET SIZE, BY BARBERSHOP-ADJACENT GROOMING CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MALE AESTHETICS MARKET SIZE, BY BARBERSHOP-ADJACENT GROOMING CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MALE AESTHETICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MALE AESTHETICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MALE AESTHETICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MALE AESTHETICS MARKET SIZE, BY FRANCHISED CHAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MALE AESTHETICS MARKET SIZE, BY FRANCHISED CHAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MALE AESTHETICS MARKET SIZE, BY FRANCHISED CHAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MALE AESTHETICS MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MALE AESTHETICS MARKET SIZE, BY MEDICAL SPAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MALE AESTHETICS MARKET SIZE, BY MEDICAL SPAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MALE AESTHETICS MARKET SIZE, BY MAINTENANCE/BOOSTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MALE AESTHETICS MARKET SIZE, BY MAINTENANCE/BOOSTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MALE AESTHETICS MARKET SIZE, BY MAINTENANCE/BOOSTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MALE AESTHETICS MARKET SIZE, BY ONE-TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MALE AESTHETICS MARKET SIZE, BY ONE-TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MALE AESTHETICS MARKET SIZE, BY ONE-TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MALE AESTHETICS MARKET SIZE, BY SERIES-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MALE AESTHETICS MARKET SIZE, BY SERIES-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MALE AESTHETICS MARKET SIZE, BY SERIES-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MALE AESTHETICS MARKET SIZE, BY LONG-LASTING (>24 MONTHS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MALE AESTHETICS MARKET SIZE, BY LONG-LASTING (>24 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MALE AESTHETICS MARKET SIZE, BY LONG-LASTING (>24 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MALE AESTHETICS MARKET SIZE, BY PERMANENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MALE AESTHETICS MARKET SIZE, BY PERMANENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MALE AESTHETICS MARKET SIZE, BY PERMANENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MALE AESTHETICS MARKET SIZE, BY SEMI-PERMANENT (6-24 MONTHS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MALE AESTHETICS MARKET SIZE, BY SEMI-PERMANENT (6-24 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MALE AESTHETICS MARKET SIZE, BY SEMI-PERMANENT (6-24 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MALE AESTHETICS MARKET SIZE, BY TEMPORARY (<=6 MONTHS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MALE AESTHETICS MARKET SIZE, BY TEMPORARY (<=6 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MALE AESTHETICS MARKET SIZE, BY TEMPORARY (<=6 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MALE AESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS MALE AESTHETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MALE AESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 208. GCC MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 209. GCC MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 210. GCC MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 211. GCC MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. GCC MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. G7 MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 240. G7 MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 241. G7 MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. G7 MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 250. NATO MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 251. NATO MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)